NCT03278067View on ClinicalTrials.gov

Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England

CompletedOBSERVATIONAL
Enrollment

23,939

Participants

Timeline

Start Date

September 12, 2017

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Influenza, Human
Interventions
OTHER

Enhanced vaccine safety surveillance

Routinely collected primary care data from up to ten general practices to support passive surveillance. Additionally, this passive surveillance will be enhanced by the use of a customized card-based ADR reporting system.

Trial Locations (1)

GU2 7XH

GSK Investigational Site, Surrey

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
collaborator

University of Surrey

OTHER

lead

GlaxoSmithKline

INDUSTRY